Overexpression of DNA repair proteins, such as BRCA1, PARP1, and RECQL4, enables cancer cells to repair DNA damage induced by chemotherapy, diminishing the effect of treatments like platinum-based drugs and PARP inhibitors. Here, BRCA1 is linked to cancer.